StockWatch
·
Medical Equipment & Supplies
Board Meeting6 Aug 2026, 02:46 pm

Prevest Denpro Board Meeting on Aug 11 to Approve Q1 Results & Final Dividend

AI Summary

Prevest Denpro Ltd has announced that its Board of Directors will convene on August 11, 2026. The primary agenda items include the consideration and approval of the Unaudited Standalone and Consolidated Financial Results for the quarter ended June 30, 2026 (Q1 FY27). Additionally, the board will discuss and recommend the Final Dividend for the Financial Year 2025-26. This meeting is being held in compliance with SEBI's Listing Obligations and Disclosure Requirements.

Key Highlights

  • Board meeting scheduled for August 11, 2026.
  • To approve Unaudited Standalone and Consolidated Financial Results for Q1 FY27.
  • Final Dividend for FY25-26 to be recommended.
  • Compliance with SEBI LODR regulations noted.